BIAF
bioAffinity Technologies, Inc.
1W: +63.4%
1M: +257.7%
3M: +212.6%
YTD: +225.4%
1Y: -54.1%
3Y: -91.6%
$3.97
+0.01 (+0.25%)
After Hours: $4.07 (+0.10, +2.52%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$17.9M
52W Range0.693-46.53
Volume13,058,355
Avg Volume7,292,008
Beta2.44
Dividend—
Analyst Ratings
Company Info
CEOMaria Zannes
Employees57
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2022-09-01
Websitebioaffinitytech.com
22211 West Interstate 10
San Antonio, TX 78257
US
San Antonio, TX 78257
US
210 698 5334
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Latest News
What's Going On With bioAffinity Technologies Stock Wednesday?
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rios Roberto | 0 | — | 2025-08-12 | |
| Oppenheimer John J. | 0 | — | 2025-08-12 | |
| Reveles Xavier Trini | A-Award | 21,604 | — | 2025-01-10 |
| GIRGENTI STEVEN | A-Award | 14,814 | — | 2025-01-10 |
| Zannes Maria | A-Award | 37,037 | — | 2025-01-10 |